Back to today’s briefing

Story perspectives

Cigna Caps GLP-1 Drug Costs at $200 Monthly

5/22/2025

42 6

Summary

Story summary

Cigna's Evernorth has struck a groundbreaking deal with Eli Lilly and Novo Nordisk, capping monthly costs for popular GLP-1 weight loss drugs Wegovy and Zepbound at just $200. This move not only eases the financial burden on employers and patients, potentially saving them up to $3,600 a year, but also streamlines access to these vital medications.

1 of 1

Story summary

Cigna's Evernorth has struck a groundbreaking deal with Eli Lilly and Novo Nordisk, capping monthly costs for popular GLP-1 weight loss drugs Wegovy and Zepbound at just $200. This move not only eases the financial burden on employers and patients, potentially saving them up to $3,600 a year, but also streamlines access to these vital medications.